Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vivid Seats (SEAT) Asset Writedowns and Impairment (2025)

Vivid Seats (SEAT) has 2 years of Asset Writedowns and Impairment data on record, last reported at -$297.4 million in Q3 2025.

  • For Q3 2025, Asset Writedowns and Impairment changed N/A year-over-year to -$297.4 million; the TTM value through Sep 2025 reached -$297.4 million, changed N/A, while the annual FY2020 figure was $3.7 million, N/A changed from the prior year.
  • Asset Writedowns and Impairment reached -$297.4 million in Q3 2025 per SEAT's latest filing, up from -$570.1 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at -$297.4 million in Q3 2025 and bottomed at -$297.4 million in Q3 2025.